COVID-19 rapid guideline: managing COVID-19. Last updated: 14 July 2022
Año de publicación: 2022
This guideline covers the management of COVID-19 for children, young people and adults in all care settings. It brings together our existing recommendations on managing COVID-19, and new recommendations on therapeutics, so that healthcare staff and those planning and delivering services can find and use them more easily.
We are continually monitoring the evidence and updating the guideline as new information emerges.
14 July 2022:
We updated recommendations on using remdesivir in hospital, and added a recommendation on vitamin D for treating COVID-19
COVID-19/drug therapy, Adrenal Cortex Hormones/therapeutic use, Antiviral Agents/therapeutic use, COVID-19/complications, Pulmonary Embolism/complications, Lung/pathology, Anticoagulants/therapeutic use, Dabigatran/therapeutic use, Heparin/therapeutic use, 4-Hydroxycoumarins/therapeutic use, Aspirin/therapeutic use